Exploring hematopoietic stem cell population in human milk and its benefits for infants: A scoping review

Abstract

Objective: To comprehensively explore hematopoietic stem cells (HSCs) in human milk, understanding their molecular markers, isolation methods, benefits for infants, and potential medical applications.

Methods: We conducted a scoping literature review following the PRISMA-ScR guidelines. This review included studies investigating HSCs in human milk, utilizing molecular markers such as CD34⁺, CD113⁺, and CD117⁺ for characterization. Both in vitro and in vivo studies exploring the morphology, function, and clinical implications of these cells were considered. The diverse range of papers reviewed were indexed in PubMed, Science Direct, Scopus, Sage Journals, and Google Scholar, published between 2010 and 2023.

Results: This scoping review explored 577 articles and selected 13 studies based on our inclusion criteria, focusing on HSCs in human milk. Most studies dilute samples prior to HSC isolation, followed by detection using markers such as CD34⁺, CD113⁺, and CD117⁺, with flow cytometry serving as the primary analysis tool, focusing on their isolation and detection methods. While no definitive benefits have been conclusively established, there is a strong belief in the potential of HSCs to positively impact infant immunity, growth, and tissue repair.

Conclusions: This review presents significant evidence supporting the presence of HSCs in human milk, identified by markers such as CD34⁺, CD113⁺, and CD117⁺. These cells show considerable potential in enhancing infant health, including immunity, tissue repair, cognitive development, and gastrointestinal health. Despite methodological variations in isolation and detection techniques, the collective findings underscore the potential clinical relevance of HSCs in human milk. Moreover, this review highlights the non-invasive accessibility of human milk as a source of HSCs and emphasizes the need for further research to unlock their therapeutic potential.

Keywords

CD34 ⁺ / Cellular components / Hematopoietic stem cells / Human milk / Stem cells

Conflict of interest statement

There are no conflicts of interest in this study.

Funding

This study is supported by the National Research and Innovation Agency of Republic of Indonesia (BRIN) -RIIM Batch-2 2022 research grants and the Institute of Education Fund Management (Lembaga Pengelola Dana Pendidikan - LPDP).

Authors’ contributions

Ghaniyyatul Khudri and Dewi Sukmawati put forward conception and design; Ghaniyyatul Khudri performed data collection, analysis, and interpretation, and article drafting; Dewi Sukmawati carried out analysis and critical revision of the article; Ghaniyyatul Khudri and Dewi Sukmawati made final approval of the article.

Publisher’s Note

The Publisher of the Journal remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

[1] Hassiotou F, Hartmann PE. At the dawn of a new discovery: The potential of breast milk stem cells. Adv Nutr 2014; 5(6):770-778.

[2] Fan Y, Chong YS, Choolani MA, Cregan MD, Chan JKY. Unravelling the mystery of stem/progenitor cells in human breast milk. PLoS One 2010; 5(12):1-11.

[3] Briere CE, McGrath JM, Jensen T, Matson A, Finck C. Breast milk stem cells: Current science and implications for preterm infants. Adv Neonatal Care 2016; 16(6):410-419.

[4] Dzierzak E, Bigas A. Blood development: Hematopoietic stem cell dependence and independence. Cell Stem Cell 2018; 22(5):639-651.

[5] Ito K, Ito K. Hematopoietic stem cell fate through metabolic control. Exp Hematol 2018; 64:1-11.

[6] Goudarzi N, Shabani R, Ebrahimi M, Baghestani A, Dehdashtian E, Vahabzadeh G, et al. Comparative phenotypic characterization of human colostrum and breast milk-derived stem cells. Hum Cell 2020; 33(2): 308-317.

[7] Indumathi S, Dhanasekaran M, Rajkumar JS, Sudarsanam D. Exploring the stem cell and non-stem cell constituents of human breast milk. Cytotechnology 2013; 65(3):385-393.

[8] Stonesifer C, Corey S, Ghanekar S, Diamandis Z, Acosta SA, Borlongan CV. Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms. Prog Neurobiol 2017; 158:94-131.

[9] Kaingade PM, Somasundaram I, Nikam AB, Sarang SA, Patel JS. Assessment of growth factors secreted by human breastmilk mesenchymal stem cells. Breastfeed Med 2016; 11(1):26-31.

[10] Sani M, Hosseini SM, Salmannejad M, Aleahmad F, Ebrahimi S, Jahanshahi S, et al. Origins of the breast milk-derived cells; an endeavor to find the cell sources. Cell Biol Int 2015; 39(5):611-618.

[11] Patki S, Kadam S, Chandra V, Bhonde R. Human breast milk is a rich source of multipotent mesenchymal stem cells. Hum Cell 2010; 23(2):35-40.

[12] Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med 2018; 169(7):467-473.

[13] Witkowska-Zimny M, Kaminska-El-Hassan E. Cells of human breast milk. Cell Mol Biol Lett 2017; 22(1):1-11.

[14] Ballard O, Morrow AL. Human milk composition: Nutrients and bioactive factorss. Pediatr Clin North Am 2013; 60(1):49-74.

[15] Kersin SG, Özek E. Breast milk stem cells: Are they magic bullets in neonatology? Turkish Arch Pediatr 2021; 56(3):187-191.

[16] Andreas NJ, Kampmann B, Mehring Le-Doare K. Human breast milk: A review on its composition and bioactivity. Early Hum Dev 2015; 91(11):629-635.

[17] Boix-Amorós A, Collado MC, Mira A. Relationship between milk microbiota, bacterial load, macronutrients, and human cells during lactation. Front Microbiol 2016; 7(4):1-9.

[18] Hassiotou F, Beltran A, Chetwynd E, Stuebe AM, Twigger AJ, Metzger P, et al. Breastmilk is a novel source of stem cells with multilineage differentiation potential. Stem Cells 2012; 30(10):2164-2174.

[19] Sani M, Ebrahimi S, Aleahmad F, Salmannejad M, Hosseini SM, Mazarei G, et al. Differentiation potential of breast milk-derived mesenchymal stem cells into hepatocyte-like cells. Tissue Eng Regen Med 2017; 14(5):587-593.

[20] Twigger AJ, Hepworth AR, Tat Lai C, Chetwynd E, Stuebe AM, Blancafort P, et al. Gene expression in breastmilk cells is associated with maternal and infant characteristics. Sci Rep 2015; 5:1-14.

[21] Trend S, De Jong E, Lloyd ML, Kok CH, Richmond P, Doherty DA, et al. Leukocyte populations in human preterm and term breast milk identified by multicolour flow cytometry. PLoS One 2015; 10(8):1-17.

[22] Yamane T. Cellular basis of embryonic hematopoiesis and its implications in prenatal erythropoiesis. Int J Mol Sci 2020; 21(24):1-12.

[23] Haas S, Trumpp A, Milsom MD. Causes and consequences of hematopoietic stem cell heterogeneity. Cell Stem Cell 2018; 22(5):627-638.

[24] Eaves CJ. Hematopoietic stem cells: Concepts, definitions, and the new reality. Blood 2015; 125(17):2605-2613.

[25] Yu V, Scadden D. Hematopoietic stem cell and its bone marrow niche. Curr Top Dev Biol 2016; 118:21-44.

[26] Pei W, Shang F, Wang X, Fanti AK, Greco A, Busch K, et al. Resolving fates and single-cell transcriptomes of hematopoietic stem cell clones by polyloxexpress barcoding. Cell Stem Cell 2020; 27(3):383-395.

[27] Höfer T, Rodewald HR. Differentiation-based model of hematopoietic stem cell functions and lineage pathways. Blood 2018; 32(11): 1106-1113.

[28] Caiado F, Pietras EM, Manz MG. Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection. J Exp Med 2021; 218(7):1-19.

[29] Valverde-Villegas JM, Naranjo-Gomez M, Durand M, Rutagwera D, Bedin AS, Kankasa C, et al. The CD133⁺ stem/progenitor-like cell subset is increased in human milk and peripheral blood of HIV-positive women. Front Cell Infect Microbiol 2020; 10:1-7.

[30] Valverde-Villegas JM, Durand M, Bedin AS, Rutagwera D, Kankasa C, Tuaillon E, et al. Large stem/progenitor-like cell subsets can also be identified in the CD45^- and CD45⁺/high populations in early human milk. J Hum Lact 2020; 36(2):303-309.

[31] Cabinian A, Sinsimer D, Tang M, Zumba O, Mehta H, Toma A, et al. Transfer of maternal immune cells by breastfeeding: Maternal cytotoxic T lymphocytes present in breast milk localize in the peyer’s patches of the nursed infant. PLoS One 2016; 11(6):1-18.

[32] Ninkina N, Kukharsky MS, Hewitt MV, Lysikova EA, Skuratovska LN, Deykin AV, et al. Stem cells in human breast milk. Hum Cell 2019; 32(3):223-230.

[33] Weissman IL, Shizuru JA. The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood 2008; 112(9):3543-3553.

[34] Ema H, Suda T, Miura Y, Nakauchi H. Colony formation of clone-sorted human hematopoietic progenitors. Blood 1990; 75(10):1941-1946.

[35] Dedeepiya VD, Rao YY, Jayakrishnan GA, Parthiban JKBC, Baskar S, Manjunath SR, et al. Index of CD34⁺ cells and mononuclear cells in the bone marrow of spinal cord injury patients of different age groups: A comparative analysis. Bone Marrow Res 2012; 2012:1-8.

[36] Coni P, Piras M, Piludu M, Lachowicz JI, Matteddu A, Coni S, et al. Exploring cell surface markers and cell-cell interactions of human breast milk stem cells. J Public Health Res 2023; 12(1):1-7.

[37] Wu J, Jin YY, Li Y, Li J, Xu J, Wu SM, et al. Dynamic change, influencing factors, and clinical impact of cellular components in human breast milk. Pediatr Res 2023; 93(6):1765-1771.

[38] Syaidah R, Maliza R, Sukmawati D. Isolation and culture methods of human breastmilk stem cells: A systematic review. Biomed 2022; 42(1):11-17.

[39] Mane S, Taneja S, Madala JS, Agarkhedkar S, Khetan M. Study of stem cells in human milk. Cureus 2022; 14(3):1-7.

[40] Ghosh A. Breast milk stem cell survival in neonate’s gut, entery into neonate circulation and adaption by the body. Curr Stem Cell Res Ther 2020; 15(2):98-101.

[41] Reinfjell T, Tremolada M, Zeltzer LK. A review of demographic, medical, and treatment variables associated with health-related quality of life (HRQOL) in survivors of hematopoietic stem cell (HSCT) and bone marrow transplantation (BMT) during childhood. Front Psychol 2017; 8:1-9.

[42] Henry C, Lavigne MJ, Robitaille M, Vachon MF, Dalle JH, Duval M, et al. Breast-feeding during infant hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11(2):105.